About Meiji
As a pioneer of quality antibiotics since its foundation in 1974, PT. Meiji Indonesia as a subsidiary of Meiji Seika Pharma Co.,Ltd. Japan, is currently one of the few players in this sector delivering highest production quality standards in Indonesia.
R&D Activities
Since its establishment in 1974, PT. Meiji Indonesia continues to research and develop quality products to meet the needs of Indonesia's domestic market as well as overseas markets such as Japan, Singapore, Thailand, and others. Our research and development activities not only focus on antibiotic products but we also do research and development on various products such as ethical prod ...
Read More
News
-
Meiji Indonesia Will Soon Launch a New Variant, SP Troches Mint!
SP Troches Mint is formulated by combining Dequalinium Chloride 0.25 mg and a mint flavor, offering a distinct sensation compared to its previous flavors of melon and strawberry.
-
22nd Maestro Lecture
PT Meiji Indonesia bekerjasama dengan SMEC dalam melaksanakan kegiatan 22nd Maestro Lecture secara online.
-
INASCRS CYBER COURSES INDUSTRIAL SYMPOSIUM
PT Meiji Indonesia memfasilitasi kegiatan-kegiatan yang dapat meningkatkan wawasan dokter-dokter di Indonesia, salah satunya melalui kegiatan Industry Symposium.
CSR
-
CSR in 2022 conducted by Factory, Bangil
Pemberian program CSR selama 4 bulan terakhir (Mei - Agustus 2022) kepada beberapa Lembaga di sekitar Pabrik Bangil
Doctor Site
Welcome to the Website of PT Meiji Indonesia, this Doctor site displays all products marketed by PT Meiji Indonesia, with categories of products such as OTC, medicines to be prescribed by doctors (Ethical Products), and Veterinary Drugs.
Read More